Researchers at ORNL explored radium’s chemistry to advance cancer treatments using ionizing radiation.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.